Cancer Research Technology
Log in Register
Menu

Info

Catalogue Number 154094
Antigen/Gene or Protein Targets Minimal deleted region of h13q14/m14qC3
Disease Keywords Chronic Lymphoblastic Leukemia
Model Knock-Out
Relevance Deletion of human chromosomal region 13q14 (mouse 14qC3) represents the most common genetic aberration in B-cell chronic lymphocytic leukaemia (CLL), a neoplasm of mature B lymphocytes. 13q14 deletions are commonly large and heterogeneous in size and affect multiple genes. Contained within the 13q14 region is the 0.11 megabase-long MDR, which encompasses the DLEU2 gene and miR-15a/16-1 cluster. Deletion of the MDR in this model organism recapitulates the full spectrum of CLL-associated lymphoproliferations in humans.
Production Details A targeting vector was devised in order to flank MDR with frt-sites. DNA fragments of the 129/Sv-14qC3 were inserted into the targeting vector. Chimeras were obtained from correctly targeted ES cell colonies after injection of the targeted W9.5 ES clones (129/SvEvTac) into blastocysts derived from C57BL/6 mice, and gave rise to MDRfl/+ mice. The chimeras were then crossed with 129/SvCAGGS-Flpe to generate a MDR null allele
Conditional No
Strain C57BL/6
Mouse Genetic Background/Cross History 129/Sv-C57Bl/6 mixed
Zygosity Homozygous
Research Area Cancer, Immunology
Notes Knockout mouse of the MDR chromosomal region in m14qC3/h13q14, which encodes the DLEU2 gene and the miR15a/16-1 microRNA cluster

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Klein et al. 2010. Cancer Cell. 17(1):28-40. PMID: 20060366.

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

Europe PMC ID: 20060366


Add a reference

References: 2 entries

Klein et al. 2010. Cancer Cell. 17(1):28-40. PMID: 20060366.

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.


Add a reference

Inventor Information